Cosmos Health Expands E-Commerce and Subscription Business to Australia, New Zealand and the Broader Oceania Region, With Sales Already UnderwayAccesswire · 2 days ago 
Cosmos Health CEO Greg Siokas Issues Letter to Shareholders Highlighting Record 2026 Revenue, U.S. Subscription Growth and Global ExpansionAccesswire · 4 days ago 
Cosmos Health Provides Update on United States Business; Q4 2026 U.S. Revenue Expected to Reach $15 Million, with Gross Profit of $10.5 Million; Active U.S. Subscriptions Up 42% from 6,287 to 8,940 in Just Five DaysAccesswire · 5 days ago 
Cosmos Health Reaches 6,287 Active U.S. Subscriptions, Substantially All Added Since Mid-September, with 60.5% of Online Checkout Orders Including a SubscriptionAccesswire · Oct 14, 2026 
Cosmos Health Reports Record Single-Day Direct-to-Consumer Sales in the United States Above $92,000, with $902,000 in Sales Over the Past 30 DaysAccesswire · Oct 13, 2026 
Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 MillionAccesswire · Oct 7, 2026Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 19, 2026 | -$0.10 | -$0.10 | Beat |
| May 20, 2026 | -$0.01 | -$0.02 | Miss |
| Apr 15, 2026 | -$0.04 | -$0.14 | Miss |
| Nov 14, 2025 | -$0.01 | -$0.17 | Miss |
| Aug 18, 2025 | $0.01 | -$0.10 | Miss |
| May 15, 2025 | -$0.03 | -$0.03 | Miss |
